Suppliers Face Winter Flu Vaccine Delays, Cutbacks
The biggest makers of seasonal flu vaccines in the U.S. are running into delays or cutting back shipments – partly because of the crunch to produce millions of doses of the new swine flu vaccine.
Drugmaker Sanofi Pasteur said it has shipped more than half of the 50.5 million doses of seasonal flu vaccine ordered and it could be November before some U.S. customers get the rest of their shipments.
Novartis AG and GlaxoSmithKline PLC said Thursday their shipments are on schedule. But theyve told customers they may get about 10 percent less than ordered.
The three companies account for about 100 million of the nations expected 114 million doses.
The delay and cutbacks have already forced some doctors offices to turn away patients and others to cancel clinics around the country. In Lyon County, Kan., the health department canceled next weeks drive-thru flu shot clinic because it used up the doses it received in August and hasnt received any more. The Jefferson City Medical Group in Missouri has depleted the partial shipment of vaccines it got for young children at its clinic.
The delay isnt surprising nor cause for big concern, said Tom Skinner, spokesman for the Centers for Disease Control and Prevention. About 70 million of the expected 114 million doses already have been delivered, he said.
Typically fewer than 100 million Americans seek winter flu shots every year. But health care providers say early demand appears to be higher this year, because of public attention to the swine flu pandemic.
Also, vaccinations for seasonal flu started unusually early this year, Skinner said. October is the traditional time when seasonal flu vaccine clinics open. Outbreaks can happen earlier, but the flu usually peaks in January or later.
“People may have to be patient and persistent” to find out when they can get the seasonal vaccine, he said.
Right now, the swine flu is the dominant virus, and it requires a separate vaccination.
Five manufacturers are scrambling to crank out plenty of vaccine against swine flu – what scientists call the 2009 H1N1 strain – and the first doses should be given early next week.
The government has ordered 250 million doses of the new vaccine from the same five companies that make the seasonal shots and nasal spray. (Ten percent of the swine flu doses have been promised to other countries.)
Cary attributed part of the backlog to its simultaneous production of 75.5 million doses of the swine flu vaccine. Also, this years seasonal flu shot includes a strain that develops more slowly in laboratories, she said.
“We understand it does create an inconvenience for some people who wanted to hold their seasonal influenza campaigns earlier,” Cary said. “We apologize for that, but were doing every thing we can.”
Novartis, based in Basel, Switzerland, halted its production of the seasonal flu vaccine in July to meet demand for the swine flu version, said company spokesman Eric Althoff. It didnt end up with as much virus stock as expected, so customers will receive a little less than ordered, he said.
University of Minnesota student Eli Cizewski-Robinson tried to get a flu shot last month, but got discouraged by the long lines and left. In the meantime, the schools health service ran out of vaccine.
“I havent been able to get one yet,” he said Thursday.